Ironwood Pharmaceuticals Inc (IRWD) Q3 2024 Earnings Report Preview: What To Expect [Yahoo! Finance]
Ironwood Pharmaceuticals, Inc. - Class A (IRWD)
Last ironwood pharmaceuticals, inc. - class a earnings: 2/13 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.ironwoodpharma.com
Company Research
Source: Yahoo! Finance
The consensus estimate for Q3 2024 revenue is $91.25 million, and the earnings are expected to come in at $0.08 per share. The full year 2024's revenue is expected to be $357.18 million and the earnings are expected to be $0.25 per share. More detailed estimate data can be found on the Forecast page Warning! GuruFocus has detected 7 Warning Signs with IRWD. Over the past 90 days, revenue estimates for Ironwood Pharmaceuticals Inc ( NASDAQ:IRWD ) for the full year 2024 have declined from $410.05 million to $357.18 million, and for 2025, the estimates have decreased from $464.50 million to $363.27 million. Earnings estimates for the full year 2024 have also been revised downward from $0.65 per share to $0.25 per share, and for 2025, from $0.84 per share to $0.49 per share. In the previous quarter of June 30, 2024, Ironwood Pharmaceuticals Inc's ( NASDAQ:IRWD ) actual revenue was $94.40 million, which missed analysts' revenue expectations of $106.996 million by -11.78%. Ironwood Ph
Show less
Read more
Impact Snapshot
Event Time:
IRWD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IRWD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IRWD alerts
High impacting Ironwood Pharmaceuticals, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
IRWD
News
- Ironwood Pharmaceuticals to Participate in the Jefferies London Healthcare ConferenceBusiness Wire
- Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.MarketBeat
- Ironwood Pharmaceuticals Inc (IRWD) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst ... [Yahoo! Finance]Yahoo! Finance
- Ironwood Pharmaceuticals, Inc. 2024 Q3 - Results - Earnings Call Presentation [Seeking Alpha]Seeking Alpha
- Ironwood Pharmaceuticals Reports Third Quarter 2024 ResultsBusiness Wire
IRWD
Earnings
- 11/7/24 - Miss
IRWD
Sec Filings
- 11/20/24 - Form 4
- 11/20/24 - Form 4
- 11/15/24 - Form 144
- IRWD's page on the SEC website